Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Treace Medical Concepts Inc TMCI

Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the... see more

NDAQ:TMCI - Post Discussion

Treace Medical Concepts Inc > TREACE MEDICAL: HELPING BUNION PATIENTS “STEP” AHEAD
View:
Post by AviseAnalytics on Oct 05, 2023 9:05am

TREACE MEDICAL: HELPING BUNION PATIENTS “STEP” AHEAD

$TMCI
 
Excited to share an article about Treace Medical Concepts, Inc. (NasdaqGS: TMCI), a medical technology company that is revolutionizing the surgical treatment of hallux valgus, commonly known as bunions, through its Lapiplasty® 3D Bunion Correction™ Procedure.
 
Treace has been experiencing an exponential increase in revenue over the last few quarters. In Q2 FY23, the company recorded revenues of $42 million, a 40% increase compared to last year. For FY22, the revenue was $141.8 million, representing a 50% YoY increase.
 
This growth trend is expected to continue in the future. Treace's proprietary Lapiplasty System is minimally invasive with a low risk of recurrence, making it superior to existing treatment options. This presents an opportunity for Treace to capture a significant share of the $5+ billion market opportunity.
 

https://www.aviseanalytics.com/treace-medical-helping-bunion-patients-step-ahead

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities